- Home
- ALBT vs KXIN Comparison
ALBT vs KXIN Comparison
Compare ALBT & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- KXIN
- Stock Information
- Founded
- ALBT 2014
- KXIN 2015
- Country
- ALBT United States
- KXIN China
- Employees
- ALBT N/A
- KXIN N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- ALBT Health Care
- KXIN Consumer Discretionary
- Exchange
- ALBT Nasdaq
- KXIN Nasdaq
- Market Cap
- ALBT 3.1M
- KXIN 2.8M
- IPO Year
- ALBT N/A
- KXIN N/A
- Fundamental
- Price
- ALBT $3.66
- KXIN $1.60
- Analyst Decision
- ALBT
- KXIN
- Analyst Count
- ALBT 0
- KXIN 0
- Target Price
- ALBT N/A
- KXIN N/A
- AVG Volume (30 Days)
- ALBT 90.7K
- KXIN 900.6K
- Earning Date
- ALBT 11-12-2024
- KXIN 01-01-0001
- Dividend Yield
- ALBT N/A
- KXIN N/A
- EPS Growth
- ALBT N/A
- KXIN N/A
- EPS
- ALBT N/A
- KXIN N/A
- Revenue
- ALBT N/A
- KXIN $12,679,000.00
- Revenue This Year
- ALBT N/A
- KXIN N/A
- Revenue Next Year
- ALBT N/A
- KXIN N/A
- P/E Ratio
- ALBT N/A
- KXIN N/A
- Revenue Growth
- ALBT N/A
- KXIN N/A
- 52 Week Low
- ALBT $2.11
- KXIN $1.20
- 52 Week High
- ALBT $21.60
- KXIN $51.00
- Technical
- Relative Strength Index (RSI)
- ALBT 51.99
- KXIN 42.58
- Support Level
- ALBT $3.20
- KXIN $1.46
- Resistance Level
- ALBT $3.81
- KXIN $1.65
- Average True Range (ATR)
- ALBT 0.41
- KXIN 0.27
- MACD
- ALBT -0.01
- KXIN 0.07
- Stochastic Oscillator
- ALBT 50.30
- KXIN 30.77
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.